154 related articles for article (PubMed ID: 35200657)
1. Micrococcin P1 and P2 from Epibiotic Bacteria Associated with Isolates of
Dzeha T; Hall MJ; Burgess JG
Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200657
[TBL] [Abstract][Full Text] [Related]
2. UV Resistance of bacteria from the Kenyan Marine cyanobacterium Moorea producens.
Dzeha T; Nyiro C; Kardasopoulos D; Mburu D; Mwafaida J; Hall MJ; Burgess JG
Microbiologyopen; 2019 Apr; 8(4):e00697. PubMed ID: 30123980
[TBL] [Abstract][Full Text] [Related]
3. Global phylogeography of toxic cyanobacteria Moorea producens reveals distinct genetic partitioning influenced by Proterozoic glacial cycles.
Curren E; Leong SCY
Harmful Algae; 2019 Jun; 86():10-19. PubMed ID: 31358269
[TBL] [Abstract][Full Text] [Related]
4. Neo-Aplysiatoxin A Isolated from Okinawan Cyanobacterium
Kawaguchi M; Satake M; Zhang BT; Xiao YY; Fukuoka M; Uchida H; Nagai H
Molecules; 2020 Jan; 25(3):. PubMed ID: 31978978
[TBL] [Abstract][Full Text] [Related]
5. A novel uncultured heterotrophic bacterial associate of the cyanobacterium Moorea producens JHB.
Cummings ME; Barbé D; Leao TF; Korobeynikov A; Engene N; Glukhov E; Gerwick WH; Gerwick L
BMC Microbiol; 2016 Aug; 16(1):198. PubMed ID: 27577966
[TBL] [Abstract][Full Text] [Related]
6. Oscillatoxin I: A New Aplysiatoxin Derivative, from a Marine Cyanobacterium.
Nagai H; Sato S; Iida K; Hayashi K; Kawaguchi M; Uchida H; Satake M
Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31234410
[TBL] [Abstract][Full Text] [Related]
7. A New Thiopeptide Antibiotic, Micrococcin P3, from a Marine-Derived Strain of the Bacterium
Wang W; Park KH; Lee J; Oh E; Park C; Kang E; Lee J; Kang H
Molecules; 2020 Sep; 25(19):. PubMed ID: 32987657
[TBL] [Abstract][Full Text] [Related]
8. Moorea producens gen. nov., sp. nov. and Moorea bouillonii comb. nov., tropical marine cyanobacteria rich in bioactive secondary metabolites.
Engene N; Rottacker EC; Kaštovský J; Byrum T; Choi H; Ellisman MH; Komárek J; Gerwick WH
Int J Syst Evol Microbiol; 2012 May; 62(Pt 5):1171-1178. PubMed ID: 21724952
[TBL] [Abstract][Full Text] [Related]
9. Biologically active new metabolites from a Florida collection of Moorea producens.
Sabry OM; Goeger DE; Gerwick WH
Nat Prod Res; 2017 Mar; 31(5):555-561. PubMed ID: 27426414
[TBL] [Abstract][Full Text] [Related]
10. Structure and Biosynthesis of Hectoramide B, a Linear Depsipeptide from Marine Cyanobacterium
Ngo TE; Ecker A; Ryu B; Guild A; Remmel A; Boudreau PD; Alexander KL; Naman CB; Glukhov E; Avalon NE; Shende VV; Thomas L; Dahesh S; Nizet V; Gerwick L; Gerwick WH
ACS Chem Biol; 2024 Mar; 19(3):619-628. PubMed ID: 38330248
[TBL] [Abstract][Full Text] [Related]
11. The toxic cosmopolitan cyanobacteria Moorena producens: insights into distribution, ecophysiology and toxicity.
Curren E; Leaw CP; Lim PT; Leong SCY
Environ Sci Pollut Res Int; 2022 Nov; 29(52):78178-78206. PubMed ID: 36190622
[TBL] [Abstract][Full Text] [Related]
12. Expanding the Described Metabolome of the Marine Cyanobacterium Moorea producens JHB through Orthogonal Natural Products Workflows.
Boudreau PD; Monroe EA; Mehrotra S; Desfor S; Korobeynikov A; Sherman DH; Murray TF; Gerwick L; Dorrestein PC; Gerwick WH
PLoS One; 2015; 10(7):e0133297. PubMed ID: 26222584
[TBL] [Abstract][Full Text] [Related]
13. New Cerebroside and Nucleoside Derivatives from a Red Sea Strain of the Marine Cyanobacterium Moorea producens.
Youssef DT; Ibrahim SR; Shaala LA; Mohamed GA; Banjar ZM
Molecules; 2016 Mar; 21(3):324. PubMed ID: 27005610
[TBL] [Abstract][Full Text] [Related]
14. A new lyngbyatoxin from the Hawaiian cyanobacterium Moorea producens.
Jiang W; Zhou W; Uchida H; Kikumori M; Irie K; Watanabe R; Suzuki T; Sakamoto B; Kamio M; Nagai H
Mar Drugs; 2014 May; 12(5):2748-59. PubMed ID: 24824022
[TBL] [Abstract][Full Text] [Related]
15. 2,3-seco-2,3-dioxo-lyngbyatoxin A from a Red Sea strain of the marine cyanobacterium Moorea producens.
Youssef DT; Shaala LA; Mohamed GA; Ibrahim SR; Banjar ZM; Badr JM; McPhail KL; Risinger AL; Mooberry SL
Nat Prod Res; 2015; 29(8):703-9. PubMed ID: 25421266
[TBL] [Abstract][Full Text] [Related]
16. Anti-Infective Secondary Metabolites of the Marine Cyanobacterium
Youssef DTA; Mufti SJ; Badiab AA; Shaala LA
Mar Drugs; 2022 Dec; 20(12):. PubMed ID: 36547915
[TBL] [Abstract][Full Text] [Related]
17. Parguerene and precarriebowmide, two classes of lipopeptides from the marine cyanobacterium Moorea producens.
Mevers E; Byrum T; Gerwick WH
J Nat Prod; 2013 Sep; 76(9):1810-4. PubMed ID: 24044577
[TBL] [Abstract][Full Text] [Related]
18. Comparative genomics uncovers the prolific and distinctive metabolic potential of the cyanobacterial genus
Leao T; Castelão G; Korobeynikov A; Monroe EA; Podell S; Glukhov E; Allen EE; Gerwick WH; Gerwick L
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3198-3203. PubMed ID: 28265051
[TBL] [Abstract][Full Text] [Related]
19. Heterologous Synthesis and Characterization of Thiocillin IV.
Son YJ; Hwang HJ; Kwon Y
ACS Chem Biol; 2023 Feb; 18(2):265-272. PubMed ID: 36693003
[TBL] [Abstract][Full Text] [Related]
20. A new malyngamide from the marine cyanobacterium Moorea producens.
Jiang W; Zhou W; Othman R; Uchida H; Watanabe R; Suzuki T; Sakamoto B; Nagai H
Nat Prod Res; 2018 Jan; 32(1):97-104. PubMed ID: 28595450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
